NCT00110253View on ClinicalTrials.gov

Duration of Skin Numbing Effect Created by the S-Caine™ Peel

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Pain
Interventions
DRUG

S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

S-Caine Peel is composed of a 1:1 eutectic mixture of 7% lidocaine, and 7% tetracaine, which was applied topically. The S Caine Peel was applied at approximately 1 mm in thickness and remained on the treatment area for 30 or 60 minutes

Trial Locations (1)

92123

Radiant Research, San Diego

All Listed Sponsors
lead

ZARS Pharma Inc.

INDUSTRY

NCT00110253 - Duration of Skin Numbing Effect Created by the S-Caine™ Peel | Biotech Hunter | Biotech Hunter